Clinical value of peripheral blood M2/M1 like monocyte ratio in the diagnosis of breast cancer and the differentiation between benign and malignant breast tumors
Acta Biochimica Polonica · 03.12.2019
DOI: 10.18388/abp.2019_2855 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biochimica Polonica, online erschienen am 03.12.2019. Verfasst von Mustafa Fadhil und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, College of Medicine, Al- Nahrain University, Baghdad, Iraq. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Background
During tumor progression, circulating monocytes and macrophages are actively recruited into tumors where they alter the tumor microenvironment to accelerate tumor progression. In response to multiple microenvironmental signals from the tumor and stromal cells, macrophages change their functional phenotypes. Based on their function, macrophages are commonly classified into both, classical M1 and alternative M2 macrophages. M2-like tumor-associated macrophages promote breast tumor growth and survival, and may migrate into the peripheral blood. However, the level of circulating M2/M1-like monocyte ratio in the peripheral blood of breast cancer patients has not been yet clarified.
Aim
To compare peripheral blood M2/M1 monocyte ratio among breast cancer patients, benign breast tumor patients and healthy subjects. Also, to investigate the role of peripheral blood M2/M1 monocyte ratio as a circulating breast cancer tumor marker and to asses the validity of this marker in differentiation between benign and malignant breast tumors.
Methods
Flow cytometry technique was used to determine the peripheral blood M2/M1 monocyte ratio in three groups of subjects, i.e. 45 patients with breast cancer, 40 patients with benign breast tumor, and 40 healthy subjects as a control group. The results of carbohydrate antigen15-3 (CA15-3) determination were analyzed comparatively.
Results
The peripheral blood M2/M1 monocyte ratio in patients with breast cancer (0.27±0.1) was significantly higher (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, College of Medicine, Al- Nahrain University, Baghdad, Iraq.
- Department of Surgery, College of Medicine, Baghdad University, Baghdad, Iraq.
Zitieren
APA
Fadhil, M., Abdul-Rasheed, O., & Al-Naqqash, M. (2019). Clinical value of peripheral blood M2/M1 like monocyte ratio in the diagnosis of breast cancer and the differentiation between benign and malignant breast tumors. Acta Biochimica Polonica. https://doi.org/10.18388/abp.2019_2855
Vancouver
Fadhil M, Abdul-Rasheed O, Al-Naqqash M. Clinical value of peripheral blood M2/M1 like monocyte ratio in the diagnosis of breast cancer and the differentiation between benign and malignant breast tumors. Acta Biochimica Polonica. 2019. doi:10.18388/abp.2019_2855
BibTeX
@article{Fadhil2019,
author = {Fadhil, Mustafa and Abdul-Rasheed, Omar and Al-Naqqash, Manwar},
title = {Clinical value of peripheral blood M2/M1 like monocyte ratio in the diagnosis of breast cancer and the differentiation between benign and malignant breast tumors},
journal = {Acta Biochimica Polonica},
year = {2019},
doi = {10.18388/abp.2019_2855}
}
EUVIMED